Broad Pipeline of Differentiated
Product Candidates
to Fight Cancer
Enrolling HER2+ Patients with
Metastatic Breast Cancer
in Phase 3 SOPHIA Study
Leading Multispecific Antibody
Technology Platforms
and Protein Engineering Expertise
Breakthrough Biologics,
Fully-integrated, Antibody-based
Development Capabilities,
Including GMP Manufacturing
Focused on Developing
Innovative Medicines
for Patients with Unmet Needs
Breakthrough Biologics,

We are a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer.

Corporate Fact Sheet

We’re Hiring!

It’s an exciting time at MacroGenics — our new GMP manufacturing suite is operational and we are looking for additional manufacturing and quality professionals to join our team. Our pipeline is expanding, as are our development and clinical teams.

Click on link below for current opportunities.

Latest News

MacroGenics to Participate in Upcoming Investor Conferences
Read More

MacroGenics Provides Update on Corporate Progress and Third Quarter 2019 Financial Results
Read More

Please note – you will leave a website owned by MacroGenics, Inc.

MacroGenics is not responsible for any content on the third party website.

Ok Close